| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Penis | 22 | 2020 | 90 | 5.060 |
Why?
|
| Piperazines | 6 | 2014 | 111 | 1.750 |
Why?
|
| Myocytes, Smooth Muscle | 6 | 2020 | 86 | 1.490 |
Why?
|
| Fibrosis | 16 | 2011 | 159 | 1.450 |
Why?
|
| Oxidative Stress | 10 | 2020 | 938 | 1.380 |
Why?
|
| Nitric Oxide Synthase | 12 | 2021 | 128 | 1.280 |
Why?
|
| Nitric Oxide Synthase Type II | 10 | 2018 | 115 | 1.070 |
Why?
|
| Nitric Oxide | 7 | 2023 | 316 | 1.070 |
Why?
|
| Rats | 38 | 2021 | 3483 | 1.000 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2011 | 94 | 0.960 |
Why?
|
| Aging | 12 | 2020 | 664 | 0.930 |
Why?
|
| Sulfones | 5 | 2012 | 44 | 0.930 |
Why?
|
| Cyclic GMP | 3 | 2019 | 47 | 0.850 |
Why?
|
| Citrulline | 2 | 2019 | 10 | 0.810 |
Why?
|
| Muscle, Smooth | 7 | 2019 | 58 | 0.760 |
Why?
|
| Animals | 51 | 2022 | 15081 | 0.730 |
Why?
|
| Arginine | 2 | 2019 | 73 | 0.720 |
Why?
|
| Apoptosis | 13 | 2020 | 1398 | 0.710 |
Why?
|
| Phosphodiesterase Inhibitors | 4 | 2007 | 34 | 0.680 |
Why?
|
| Olacaceae | 1 | 2018 | 2 | 0.640 |
Why?
|
| Paullinia | 1 | 2018 | 3 | 0.640 |
Why?
|
| Transforming Growth Factor beta1 | 6 | 2011 | 93 | 0.630 |
Why?
|
| Erectile Dysfunction | 5 | 2021 | 38 | 0.600 |
Why?
|
| Neuroprotective Agents | 3 | 2012 | 245 | 0.580 |
Why?
|
| Imidazoles | 2 | 2006 | 126 | 0.530 |
Why?
|
| Male | 37 | 2022 | 20025 | 0.510 |
Why?
|
| Ganglia | 1 | 2014 | 10 | 0.500 |
Why?
|
| Rats, Inbred F344 | 13 | 2014 | 245 | 0.500 |
Why?
|
| Rats, Sprague-Dawley | 10 | 2019 | 1618 | 0.470 |
Why?
|
| Sulfonamides | 1 | 2014 | 80 | 0.470 |
Why?
|
| Penile Induration | 4 | 2008 | 25 | 0.460 |
Why?
|
| Ganglia, Autonomic | 1 | 2012 | 4 | 0.430 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 1 | 2012 | 4 | 0.430 |
Why?
|
| Estrogens | 2 | 2006 | 202 | 0.420 |
Why?
|
| Gene Expression | 5 | 2012 | 674 | 0.420 |
Why?
|
| Penile Erection | 5 | 2014 | 26 | 0.390 |
Why?
|
| Impotence, Vasculogenic | 5 | 2009 | 13 | 0.380 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 5 | 2 | 2021 | 8 | 0.380 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2020 | 162 | 0.370 |
Why?
|
| Vagina | 2 | 2009 | 81 | 0.360 |
Why?
|
| Extracellular Matrix | 1 | 2011 | 115 | 0.360 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 98 | 0.360 |
Why?
|
| Vascular Diseases | 2 | 2007 | 30 | 0.350 |
Why?
|
| Cells, Cultured | 8 | 2019 | 1518 | 0.340 |
Why?
|
| Purines | 4 | 2014 | 38 | 0.340 |
Why?
|
| Peripheral Nerves | 1 | 2008 | 14 | 0.330 |
Why?
|
| Transforming Growth Factor beta | 5 | 2008 | 197 | 0.330 |
Why?
|
| Immunohistochemistry | 10 | 2010 | 893 | 0.310 |
Why?
|
| Antioxidants | 1 | 2011 | 416 | 0.310 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2009 | 130 | 0.310 |
Why?
|
| Calcitriol | 3 | 2012 | 31 | 0.290 |
Why?
|
| Pituitary-Adrenal System | 2 | 2006 | 39 | 0.280 |
Why?
|
| Collagen | 4 | 2010 | 172 | 0.280 |
Why?
|
| Muscle, Skeletal | 4 | 2011 | 282 | 0.280 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2006 | 53 | 0.280 |
Why?
|
| Neurosecretory Systems | 1 | 2006 | 16 | 0.270 |
Why?
|
| Obesity | 3 | 2022 | 1067 | 0.270 |
Why?
|
| Adrenal Glands | 1 | 2006 | 19 | 0.270 |
Why?
|
| Hypothalamus | 2 | 2020 | 129 | 0.250 |
Why?
|
| Actins | 4 | 2010 | 148 | 0.250 |
Why?
|
| Arteries | 2 | 2020 | 65 | 0.230 |
Why?
|
| Nitric Oxide Synthase Type I | 7 | 2012 | 56 | 0.230 |
Why?
|
| Cell Differentiation | 6 | 2020 | 587 | 0.230 |
Why?
|
| Neural Crest | 1 | 2023 | 23 | 0.230 |
Why?
|
| Mice | 13 | 2022 | 5913 | 0.230 |
Why?
|
| Nerve Tissue | 2 | 2014 | 7 | 0.220 |
Why?
|
| Morphine | 2 | 2013 | 85 | 0.220 |
Why?
|
| Hypoglycemic Agents | 3 | 2010 | 160 | 0.220 |
Why?
|
| Interferon-gamma | 1 | 2023 | 250 | 0.210 |
Why?
|
| Spinal Cord | 1 | 2003 | 94 | 0.210 |
Why?
|
| Telencephalon | 1 | 2002 | 14 | 0.210 |
Why?
|
| GAP-43 Protein | 1 | 2002 | 9 | 0.210 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2002 | 34 | 0.210 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2003 | 137 | 0.210 |
Why?
|
| Nucleotides, Cyclic | 1 | 2021 | 6 | 0.200 |
Why?
|
| Appetite | 2 | 2020 | 21 | 0.200 |
Why?
|
| Muscle Development | 2 | 2012 | 45 | 0.200 |
Why?
|
| Nerve Degeneration | 1 | 2002 | 107 | 0.200 |
Why?
|
| Blotting, Western | 10 | 2009 | 859 | 0.200 |
Why?
|
| Neurons | 6 | 2020 | 1175 | 0.200 |
Why?
|
| Neurogenesis | 3 | 2020 | 58 | 0.200 |
Why?
|
| Drosophila Proteins | 1 | 2003 | 171 | 0.190 |
Why?
|
| Adipose Tissue | 1 | 2022 | 177 | 0.190 |
Why?
|
| Carrier Proteins | 1 | 2003 | 305 | 0.190 |
Why?
|
| Hyperphagia | 1 | 2020 | 14 | 0.190 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2020 | 23 | 0.190 |
Why?
|
| Disease Models, Animal | 5 | 2014 | 1371 | 0.180 |
Why?
|
| Animal Feed | 1 | 2020 | 43 | 0.180 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2010 | 133 | 0.170 |
Why?
|
| Animals, Newborn | 1 | 2020 | 343 | 0.170 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2019 | 36 | 0.170 |
Why?
|
| Nitrites | 1 | 2019 | 46 | 0.170 |
Why?
|
| Stem Cell Transplantation | 2 | 2009 | 31 | 0.160 |
Why?
|
| Enzyme Inhibitors | 4 | 2011 | 433 | 0.160 |
Why?
|
| Multipotent Stem Cells | 3 | 2023 | 16 | 0.160 |
Why?
|
| Mice, Knockout | 2 | 2011 | 933 | 0.150 |
Why?
|
| Hippocampus | 3 | 2008 | 561 | 0.150 |
Why?
|
| Thiazolidinediones | 2 | 2009 | 50 | 0.150 |
Why?
|
| Fibroblasts | 4 | 2009 | 272 | 0.150 |
Why?
|
| Myostatin | 4 | 2011 | 63 | 0.150 |
Why?
|
| RNA, Messenger | 6 | 2013 | 1207 | 0.140 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2013 | 54 | 0.140 |
Why?
|
| Triazines | 2 | 2006 | 20 | 0.140 |
Why?
|
| RNA, Small Interfering | 3 | 2008 | 409 | 0.140 |
Why?
|
| Cell Proliferation | 3 | 2011 | 1198 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2009 | 643 | 0.140 |
Why?
|
| Proprotein Convertase 1 | 2 | 2013 | 11 | 0.130 |
Why?
|
| Proprotein Convertase 2 | 2 | 2013 | 21 | 0.130 |
Why?
|
| Heme Oxygenase-1 | 1 | 2014 | 51 | 0.120 |
Why?
|
| Signal Transduction | 5 | 2012 | 1908 | 0.120 |
Why?
|
| Cholecalciferol | 1 | 2014 | 20 | 0.120 |
Why?
|
| Reactive Oxygen Species | 3 | 2007 | 461 | 0.120 |
Why?
|
| Cholinergic Fibers | 2 | 2006 | 10 | 0.120 |
Why?
|
| Group II Phospholipases A2 | 1 | 2014 | 3 | 0.120 |
Why?
|
| Brain | 2 | 2013 | 1346 | 0.120 |
Why?
|
| Up-Regulation | 2 | 2014 | 513 | 0.120 |
Why?
|
| Nerve Growth Factor | 1 | 2014 | 30 | 0.120 |
Why?
|
| Neurites | 1 | 2014 | 39 | 0.120 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2013 | 15 | 0.110 |
Why?
|
| Morphine Dependence | 1 | 2013 | 25 | 0.110 |
Why?
|
| Narcotics | 1 | 2013 | 32 | 0.110 |
Why?
|
| Gene Expression Regulation | 6 | 2021 | 1015 | 0.110 |
Why?
|
| Pregnancy | 4 | 2022 | 1549 | 0.110 |
Why?
|
| Neurturin | 1 | 2012 | 2 | 0.110 |
Why?
|
| Pelvis | 1 | 2012 | 14 | 0.110 |
Why?
|
| Myocytes, Cardiac | 1 | 2014 | 166 | 0.110 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2012 | 64 | 0.100 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 73 | 0.100 |
Why?
|
| Eating | 1 | 2013 | 166 | 0.100 |
Why?
|
| Molsidomine | 1 | 2011 | 4 | 0.100 |
Why?
|
| Nitric Oxide Donors | 1 | 2011 | 18 | 0.100 |
Why?
|
| Allopurinol | 1 | 2011 | 12 | 0.100 |
Why?
|
| Analgesics, Opioid | 1 | 2013 | 197 | 0.100 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2011 | 8 | 0.100 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2011 | 14 | 0.100 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2011 | 22 | 0.100 |
Why?
|
| Epidermal Growth Factor | 1 | 2011 | 68 | 0.090 |
Why?
|
| Xanthine Dehydrogenase | 1 | 2010 | 2 | 0.090 |
Why?
|
| Aorta | 2 | 2009 | 167 | 0.090 |
Why?
|
| Cytokines | 1 | 2014 | 602 | 0.090 |
Why?
|
| Phospholipases A2 | 1 | 2010 | 9 | 0.090 |
Why?
|
| Myoblasts | 2 | 2008 | 27 | 0.090 |
Why?
|
| Denervation | 2 | 2007 | 27 | 0.090 |
Why?
|
| Stem Cells | 2 | 2008 | 141 | 0.090 |
Why?
|
| Rats, Inbred BN | 3 | 2005 | 21 | 0.090 |
Why?
|
| Cell Shape | 1 | 2010 | 35 | 0.090 |
Why?
|
| Isoenzymes | 1 | 2010 | 161 | 0.090 |
Why?
|
| Tissue Scaffolds | 1 | 2009 | 25 | 0.090 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2010 | 62 | 0.090 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2009 | 7 | 0.090 |
Why?
|
| Feeding Behavior | 1 | 2013 | 454 | 0.080 |
Why?
|
| Tunica Media | 1 | 2009 | 12 | 0.080 |
Why?
|
| Endothelium, Vascular | 1 | 2011 | 237 | 0.080 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2008 | 43 | 0.080 |
Why?
|
| Endothelium | 1 | 2008 | 31 | 0.080 |
Why?
|
| Kidney Tubules | 1 | 2009 | 33 | 0.080 |
Why?
|
| Caspase 2 | 1 | 2008 | 7 | 0.080 |
Why?
|
| Random Allocation | 1 | 2008 | 139 | 0.080 |
Why?
|
| Insulin | 1 | 2010 | 236 | 0.080 |
Why?
|
| Cell Cycle | 1 | 2010 | 326 | 0.080 |
Why?
|
| Group V Phospholipases A2 | 1 | 2007 | 1 | 0.080 |
Why?
|
| Mesoderm | 1 | 2008 | 70 | 0.080 |
Why?
|
| Carbolines | 1 | 2007 | 15 | 0.080 |
Why?
|
| Fetal Nutrition Disorders | 1 | 2007 | 9 | 0.070 |
Why?
|
| Prostatectomy | 1 | 2007 | 63 | 0.070 |
Why?
|
| PPAR gamma | 1 | 2007 | 53 | 0.070 |
Why?
|
| Humans | 11 | 2023 | 37093 | 0.070 |
Why?
|
| Pyrrolidonecarboxylic Acid | 1 | 2006 | 7 | 0.070 |
Why?
|
| Proprotein Convertases | 1 | 2006 | 8 | 0.070 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 2006 | 13 | 0.070 |
Why?
|
| Malnutrition | 1 | 2007 | 44 | 0.070 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2006 | 23 | 0.070 |
Why?
|
| Hypothyroidism | 1 | 2006 | 18 | 0.070 |
Why?
|
| Diabetic Angiopathies | 1 | 2006 | 21 | 0.070 |
Why?
|
| Gene Transfer Techniques | 1 | 2006 | 47 | 0.070 |
Why?
|
| Protein Precursors | 1 | 2006 | 61 | 0.070 |
Why?
|
| Estradiol | 1 | 2008 | 262 | 0.070 |
Why?
|
| Prosencephalon | 1 | 2006 | 25 | 0.070 |
Why?
|
| Rats, Wistar | 1 | 2006 | 233 | 0.070 |
Why?
|
| Feedback, Physiological | 1 | 2006 | 31 | 0.070 |
Why?
|
| Superoxide Dismutase | 1 | 2006 | 155 | 0.070 |
Why?
|
| Steroids | 1 | 2006 | 43 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2007 | 290 | 0.070 |
Why?
|
| Administration, Oral | 1 | 2006 | 224 | 0.060 |
Why?
|
| Female | 6 | 2022 | 20969 | 0.060 |
Why?
|
| Germ Cells | 1 | 2005 | 73 | 0.060 |
Why?
|
| Models, Animal | 2 | 2021 | 134 | 0.060 |
Why?
|
| Plasminogen Inactivators | 1 | 2004 | 3 | 0.060 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2004 | 14 | 0.060 |
Why?
|
| Rats, Zucker | 3 | 2009 | 23 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 2 | 2005 | 360 | 0.060 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2004 | 47 | 0.060 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 36 | 0.060 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2003 | 19 | 0.060 |
Why?
|
| SOX Transcription Factors | 1 | 2023 | 3 | 0.060 |
Why?
|
| Mouth Mucosa | 1 | 2023 | 34 | 0.060 |
Why?
|
| Narcotic Antagonists | 2 | 2013 | 57 | 0.060 |
Why?
|
| Dyneins | 1 | 2003 | 7 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2004 | 444 | 0.050 |
Why?
|
| Phosphorylation | 3 | 2013 | 928 | 0.050 |
Why?
|
| Weaning | 1 | 2022 | 15 | 0.050 |
Why?
|
| Brain Chemistry | 1 | 2003 | 140 | 0.050 |
Why?
|
| Septal Nuclei | 1 | 2002 | 3 | 0.050 |
Why?
|
| Receptors, Calcitriol | 2 | 2014 | 69 | 0.050 |
Why?
|
| Neural Pathways | 1 | 2002 | 124 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2023 | 194 | 0.050 |
Why?
|
| Virus Replication | 1 | 2023 | 278 | 0.050 |
Why?
|
| Reproduction | 1 | 2002 | 71 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2013 | 1609 | 0.050 |
Why?
|
| Databases, Genetic | 1 | 2021 | 93 | 0.050 |
Why?
|
| Cell Line | 3 | 2012 | 1354 | 0.050 |
Why?
|
| Adiposity | 1 | 2022 | 154 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 2021 | 90 | 0.050 |
Why?
|
| Satiation | 1 | 2020 | 9 | 0.050 |
Why?
|
| Agouti-Related Protein | 1 | 2020 | 12 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 120 | 0.050 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 58 | 0.050 |
Why?
|
| Mitochondria | 1 | 2004 | 487 | 0.050 |
Why?
|
| Diet | 2 | 2022 | 801 | 0.050 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2020 | 80 | 0.040 |
Why?
|
| Electroporation | 3 | 2006 | 18 | 0.040 |
Why?
|
| Cell Nucleus | 2 | 2014 | 366 | 0.040 |
Why?
|
| Genetic Vectors | 3 | 2006 | 158 | 0.040 |
Why?
|
| Computational Biology | 1 | 2021 | 293 | 0.040 |
Why?
|
| Body Weight | 2 | 2013 | 434 | 0.040 |
Why?
|
| Protein Transport | 2 | 2014 | 302 | 0.040 |
Why?
|
| Plasmids | 3 | 2006 | 246 | 0.040 |
Why?
|
| Tissue Distribution | 2 | 2010 | 207 | 0.040 |
Why?
|
| Benzhydryl Compounds | 1 | 2018 | 43 | 0.040 |
Why?
|
| Phenols | 1 | 2018 | 80 | 0.040 |
Why?
|
| Time Factors | 2 | 2013 | 1742 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2014 | 153 | 0.030 |
Why?
|
| PC12 Cells | 1 | 2014 | 93 | 0.030 |
Why?
|
| Drug Implants | 1 | 2013 | 21 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2013 | 33 | 0.030 |
Why?
|
| Pain Threshold | 1 | 2013 | 28 | 0.030 |
Why?
|
| Pituitary Gland | 1 | 2013 | 63 | 0.030 |
Why?
|
| Naltrexone | 1 | 2013 | 38 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 143 | 0.030 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2012 | 4 | 0.030 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2012 | 9 | 0.030 |
Why?
|
| beta-Galactosidase | 2 | 2002 | 35 | 0.030 |
Why?
|
| Adenoviridae | 2 | 2002 | 62 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2012 | 43 | 0.030 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2013 | 107 | 0.030 |
Why?
|
| Testis | 2 | 2005 | 187 | 0.030 |
Why?
|
| Electric Stimulation | 2 | 2002 | 184 | 0.030 |
Why?
|
| DNA, Complementary | 2 | 2002 | 191 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 161 | 0.020 |
Why?
|
| MyoD Protein | 1 | 2011 | 9 | 0.020 |
Why?
|
| Growth Differentiation Factors | 1 | 2011 | 7 | 0.020 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2011 | 23 | 0.020 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2011 | 23 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2011 | 59 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 286 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1039 | 0.020 |
Why?
|
| Genes, cdc | 1 | 2010 | 8 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2010 | 167 | 0.020 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2010 | 30 | 0.020 |
Why?
|
| Biological Assay | 1 | 2010 | 59 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 2010 | 30 | 0.020 |
Why?
|
| Uterine Prolapse | 1 | 2009 | 3 | 0.020 |
Why?
|
| Muscle Cells | 1 | 2009 | 11 | 0.020 |
Why?
|
| Intestine, Small | 1 | 2009 | 25 | 0.020 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2010 | 43 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2009 | 90 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2009 | 29 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 306 | 0.020 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2008 | 16 | 0.020 |
Why?
|
| Caspase 9 | 1 | 2008 | 30 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2010 | 131 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2009 | 122 | 0.020 |
Why?
|
| Mineralocorticoids | 1 | 2008 | 1 | 0.020 |
Why?
|
| Adrenal Cortex | 1 | 2008 | 3 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 2008 | 133 | 0.020 |
Why?
|
| Smad Proteins | 1 | 2008 | 12 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 77 | 0.020 |
Why?
|
| Aldehydes | 1 | 2008 | 69 | 0.020 |
Why?
|
| Indolizines | 1 | 2007 | 4 | 0.020 |
Why?
|
| Follistatin | 1 | 2008 | 27 | 0.020 |
Why?
|
| Carbamates | 1 | 2007 | 12 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2008 | 86 | 0.020 |
Why?
|
| Arterioles | 1 | 2007 | 19 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2008 | 152 | 0.020 |
Why?
|
| Mesenteric Arteries | 1 | 2007 | 20 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 218 | 0.020 |
Why?
|
| Lac Operon | 1 | 2006 | 21 | 0.020 |
Why?
|
| Neuroglia | 1 | 2007 | 124 | 0.020 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2006 | 25 | 0.020 |
Why?
|
| Kidney | 1 | 2009 | 337 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 515 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2006 | 136 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 626 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2008 | 435 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2006 | 151 | 0.020 |
Why?
|
| Transfection | 1 | 2006 | 523 | 0.020 |
Why?
|
| Phenotype | 1 | 2008 | 689 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2006 | 173 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2009 | 646 | 0.020 |
Why?
|
| Base Sequence | 1 | 2006 | 997 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2004 | 53 | 0.010 |
Why?
|
| Inflammation | 1 | 2009 | 618 | 0.010 |
Why?
|
| Pentoxifylline | 1 | 2003 | 6 | 0.010 |
Why?
|
| Age Factors | 1 | 2007 | 1033 | 0.010 |
Why?
|
| Caspases | 1 | 2004 | 147 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2004 | 117 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2004 | 223 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 2004 | 105 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2004 | 207 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2002 | 53 | 0.010 |
Why?
|
| Collagen Type I | 1 | 2002 | 30 | 0.010 |
Why?
|
| Models, Biological | 1 | 2006 | 677 | 0.010 |
Why?
|
| Vimentin | 1 | 2002 | 37 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2008 | 485 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 623 | 0.010 |
Why?
|
| Hypertension | 1 | 2008 | 796 | 0.010 |
Why?
|
| Aged | 1 | 2008 | 6741 | 0.010 |
Why?
|
| Middle Aged | 1 | 2008 | 10129 | 0.010 |
Why?
|